A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment An investigator in a trial of daraxonrasib believes it could open the floodgates for better therapies

https://www.statnews.com/2026/04/17/revolution-medicines-daraxonrasib-clinical-trial-readout-loud-podcast-transcript/ By Adam Feuerstein, Allison DeAngelis, and Elaine ChenApril 17, 2026